These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

343 related articles for article (PubMed ID: 17470831)

  • 1. Infliximab plus prednisone or placebo plus prednisone for the initial treatment of polymyalgia rheumatica: a randomized trial.
    Salvarani C; Macchioni P; Manzini C; Paolazzi G; Trotta A; Manganelli P; Cimmino M; Gerli R; Catanoso MG; Boiardi L; Cantini F; Klersy C; Hunder GG
    Ann Intern Med; 2007 May; 146(9):631-9. PubMed ID: 17470831
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prednisone plus methotrexate for polymyalgia rheumatica: a randomized, double-blind, placebo-controlled trial.
    Caporali R; Cimmino MA; Ferraccioli G; Gerli R; Klersy C; Salvarani C; Montecucco C;
    Ann Intern Med; 2004 Oct; 141(7):493-500. PubMed ID: 15466766
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Summaries for patients. Adding infliximab to the treatment regimen for polymyalgia rheumatica.
    Ann Intern Med; 2007 May; 146(9):I20. PubMed ID: 17470827
    [No Abstract]   [Full Text] [Related]  

  • 4. Infliximab for maintenance of glucocorticosteroid-induced remission of giant cell arteritis: a randomized trial.
    Hoffman GS; Cid MC; Rendt-Zagar KE; Merkel PA; Weyand CM; Stone JH; Salvarani C; Xu W; Visvanathan S; Rahman MU;
    Ann Intern Med; 2007 May; 146(9):621-30. PubMed ID: 17470830
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of Tocilizumab on Disease Activity in Patients With Active Polymyalgia Rheumatica Receiving Glucocorticoid Therapy: A Randomized Clinical Trial.
    Devauchelle-Pensec V; Carvajal-Alegria G; Dernis E; Richez C; Truchetet ME; Wendling D; Toussirot E; Perdriger A; Gottenberg JE; Felten R; Fautrel BJ; Chiche L; Hilliquin P; Le Henaff C; Dervieux B; Direz G; Chary-Valckenaere I; Cornec D; Guellec D; Marhadour T; Nowak E; Saraux A
    JAMA; 2022 Sep; 328(11):1053-1062. PubMed ID: 36125471
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long-term follow-up of polymyalgia rheumatica patients treated with methotrexate and steroids.
    Cimmino MA; Salvarani C; Macchioni P; Gerli R; Bartoloni Bocci E; Montecucco C; Caporali R;
    Clin Exp Rheumatol; 2008; 26(3):395-400. PubMed ID: 18578959
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Can methotrexate be used as a steroid sparing agent in the treatment of polymyalgia rheumatica and giant cell arteritis?
    van der Veen MJ; Dinant HJ; van Booma-Frankfort C; van Albada-Kuipers GA; Bijlsma JW
    Ann Rheum Dis; 1996 Apr; 55(4):218-23. PubMed ID: 8733437
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy of first-line tocilizumab therapy in early polymyalgia rheumatica: a prospective longitudinal study.
    Devauchelle-Pensec V; Berthelot JM; Cornec D; Renaudineau Y; Marhadour T; Jousse-Joulin S; Querellou S; Garrigues F; De Bandt M; Gouillou M; Saraux A
    Ann Rheum Dis; 2016 Aug; 75(8):1506-10. PubMed ID: 26929219
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Summaries for patients. Prednisone plus methotrexate for polymyalgia rheumatica.
    Ann Intern Med; 2004 Oct; 141(7):I12. PubMed ID: 15466761
    [No Abstract]   [Full Text] [Related]  

  • 10. Sarilumab for Relapse of Polymyalgia Rheumatica during Glucocorticoid Taper.
    Spiera RF; Unizony S; Warrington KJ; Sloane J; Giannelou A; Nivens MC; Akinlade B; Wong W; Bhore R; Lin Y; Buttgereit F; Devauchelle-Pensec V; Rubbert-Roth A; Yancopoulos GD; Marrache F; Patel N; Dasgupta B;
    N Engl J Med; 2023 Oct; 389(14):1263-1272. PubMed ID: 37792612
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Infliximab is ineffective against giant cell arteritis and polymyalgia rheumatica].
    Krüger K
    Z Rheumatol; 2007 Oct; 66(6):536-7. PubMed ID: 17849125
    [No Abstract]   [Full Text] [Related]  

  • 12. 1-year results of treatment with rituximab in polymyalgia rheumatica: an extension study of a randomised double-blind placebo-controlled trial.
    Bolhuis TE; Marsman DE; den Broeder AA; den Broeder N; van der Maas A
    Lancet Rheumatol; 2023 Apr; 5(4):e208-e214. PubMed ID: 38251523
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Combined treatment of giant-cell arteritis with methotrexate and prednisone. a randomized, double-blind, placebo-controlled trial.
    Jover JA; Hernández-García C; Morado IC; Vargas E; Bañares A; Fernández-Gutiérrez B
    Ann Intern Med; 2001 Jan; 134(2):106-14. PubMed ID: 11177313
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Methotrexate for induction of remission in refractory Crohn's disease.
    McDonald JW; Tsoulis DJ; Macdonald JK; Feagan BG
    Cochrane Database Syst Rev; 2012 Dec; 12():CD003459. PubMed ID: 23235598
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tumor necrosis factor blocking agents in polymyalgia rheumatica and giant cell arteritis.
    Salvarani C; Hunder GG
    Ann Intern Med; 2008 Jan; 148(2):167-8; author reply 168. PubMed ID: 18195345
    [No Abstract]   [Full Text] [Related]  

  • 16. Tocilizumab in patients with new onset polymyalgia rheumatica (PMR-SPARE): a phase 2/3 randomised controlled trial.
    Bonelli M; Radner H; Kerschbaumer A; Mrak D; Durechova M; Stieger J; Husic R; Mandl P; Smolen JS; Dejaco C; Aletaha D
    Ann Rheum Dis; 2022 Jun; 81(6):838-844. PubMed ID: 35210264
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Treatment of polymyalgia rheumatica: a systematic review.
    Hernández-Rodríguez J; Cid MC; López-Soto A; Espigol-Frigolé G; Bosch X
    Arch Intern Med; 2009 Nov; 169(20):1839-50. PubMed ID: 19901135
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Adalimumab induction therapy for Crohn disease previously treated with infliximab: a randomized trial.
    Sandborn WJ; Rutgeerts P; Enns R; Hanauer SB; Colombel JF; Panaccione R; D'Haens G; Li J; Rosenfeld MR; Kent JD; Pollack PF
    Ann Intern Med; 2007 Jun; 146(12):829-38. PubMed ID: 17470824
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Treatment of refractory polymyalgia rheumatica with infliximab: a pilot study.
    Salvarani C; Cantini F; Niccoli L; Catanoso MG; Macchioni P; Pulsatelli L; Padula A; Olivieri I; Boiardi L
    J Rheumatol; 2003 Apr; 30(4):760-3. PubMed ID: 12672196
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Treatment of polymyalgia rheumatica and giant cell arteritis: are we any further forward?
    Luqmani R
    Ann Intern Med; 2007 May; 146(9):674-6. PubMed ID: 17470835
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 18.